keratoconu
progress
corneal
thin
ectat
condit
affect
vision
recent
advanc
corneal
topographi
measur
help
advanc
proper
diagnosi
condit
increas
research
clinic
interest
diseas
etiopathogenesi
consider
progress
achiev
understand
progress
diseas
tear
fluid
play
major
role
progress
review
discuss
import
tear
fluid
sourc
biomark
keratoconu
advanc
technolog
help
map
complex
tear
therebi
molecular
readout
diseas
expand
knowledg
tear
proteom
lipidom
metabolom
open
new
avenu
studi
keratoconu
identifi
probabl
prognost
diagnost
biomark
diseas
multidimension
approach
analyz
tear
fluid
patient
layer
proteom
lipidom
metabolom
necessari
effect
decod
keratoconu
therebi
identifi
target
treatment
keratoconu
progress
asymmetr
corneal
ectasia
character
thin
protrus
cornea
lead
irregular
astigmat
myopia
therebi
affect
visual
perform
diseas
clinic
diagnos
corneal
thin
steepen
along
presenc
iron
oxid
hemosiderin
deposit
corneal
mid
peripheri
fleischer
ring
around
subject
exhibit
vogt
striae
fine
stress
line
caus
stretch
corneal
thin
although
clinic
sign
help
diagnosi
keratoconu
typic
confirm
corneal
topographi
tomographi
although
keratoconu
bilater
certain
scenario
clinic
topograph
sign
present
one
eye
unilater
keratoconu
wherein
eye
diagnos
form
frust
keratoconu
onset
diseas
occur
puberti
progress
third
decad
life
henc
sever
grade
propos
keratoconu
differenti
normal
eye
keratocon
eye
base
clinic
sign
corneal
topographi
indic
keratoconu
report
affect
individu
greater
preval
asian
indic
role
ethnic
genet
environment
factor
contribut
diseas
patholog
although
atopi
eye
rub
ocular
allergi
syndrom
tapetoretin
degener
associ
keratoconu
etiolog
pathogenesi
still
remain
unclear
despit
associ
variou
genet
loci
twin
famili
studi
gener
consensu
remain
diseas
polygen
depend
ocular
surfac
tear
molecular
express
chang
tear
fluid
import
sourc
inform
understand
ocular
physiolog
larg
number
proteas
proteas
inhibitor
identifi
tear
zhou
et
al
identifi
protein
tear
fluid
majorli
involv
carbohydr
catabol
proteolysi
protein
transport
besid
immun
respons
regul
apoptosi
diseas
specif
molecular
signatur
tear
fluid
analysi
help
understand
etiolog
diseas
help
prognosi
addit
tear
fluid
serv
optim
sourc
molecular
target
treat
ocular
diseas
condit
review
attempt
discuss
concis
manner
molecular
marker
keratoconu
recent
discov
import
tear
film
sourc
biomark
understand
etiopatholog
well
prognosi
diseas
tear
film
essenti
maintain
ocular
homeostasi
monitor
ocular
surfac
condit
tear
fluid
secret
lacrim
gland
complex
matrix
compris
inner
mucin
layer
middl
aqueou
layer
outer
lipid
layer
compos
lipid
protein
peptid
proteas
proteas
inhibitor
metabolit
lipid
layer
provid
lubric
stabil
tear
film
play
protect
role
prevent
cornea
dri
shield
pathogen
tear
fluid
help
nourish
corneal
epithelium
anterior
stroma
deliv
nutrient
metabol
product
constitut
tear
film
influenc
diseas
specif
chang
molecular
marker
diagnost
valu
anoth
facet
tear
fluid
analysi
lipidom
analysi
tear
fluid
lipidom
rantamaki
et
al
show
polar
lipid
major
tear
lipid
phospholipid
composit
tear
lipid
differ
distinctli
meibomian
gland
recent
comprehens
analysi
human
tear
fluid
identifi
lipid
speci
belong
major
lipid
class
besid
lipidom
metabolom
analysi
tear
healthi
subject
use
mass
spectrometri
reveal
tear
metabolit
differ
class
tear
biomark
discoveri
tear
fluid
sourc
biomark
protein
lipocalin
lcn
lysozym
lyz
lactoferrin
ltf
serum
albumin
albu
prolin
rich
repeat
protein
prr
constitut
abund
protein
tear
fluid
inflammatori
protein
observ
tear
patient
long
term
glaucoma
medic
tear
fluid
protein
also
consid
mean
screen
diabet
retinopathi
tear
protein
report
alter
patient
keratoconu
without
contact
len
wear
compar
control
tear
composit
shown
alter
variou
inflammatori
diseas
like
dri
eye
syndrom
de
keratoconu
primari
open
angl
glaucoma
grave
ophthalmopathi
tear
fluid
studi
sourc
biomark
diagnosi
system
condit
breast
cancer
diabet
multipl
sclerosi
sever
acut
respiratori
syndrom
sar
report
highlight
import
tear
studi
ocular
condit
also
readout
system
condit
similar
tear
proteom
tear
lipidom
metabolom
also
undergo
chang
keratoconu
observ
ocular
diseas
de
reduc
level
wax
ester
satur
fatti
acyl
moieti
de
patient
observ
besid
lipid
tear
metabolom
also
studi
understand
diseas
patholog
use
nuclear
magnet
reson
nmr
spectroscopi
level
metabolit
found
vari
tear
de
patient
compar
healthi
subject
advanc
technolog
mass
spectrometri
nmr
help
studi
understand
molecular
chang
tear
proteom
lipidom
metabolom
relat
ocular
diseas
condit
storag
mainten
collect
tear
fluid
proper
temperatur
condit
critic
success
discov
biomark
tear
fluid
patient
noninvas
collect
either
use
glass
capillari
schirmer
strip
howev
schirmer
strip
method
collect
tear
consid
effect
minimum
discomfort
patient
often
part
de
ocular
surfac
diseas
test
patient
alreadi
undergo
clinic
sinc
tear
composit
complex
variou
proteolyt
enzym
cytokin
metabolit
tear
fluid
store
subzero
temperatur
ie
reduct
total
tear
protein
concentr
observ
store
room
temperatur
h
genet
variat
one
factor
influenc
incid
keratoconu
genet
predisposit
keratoconu
famili
monozygot
twin
well
establish
singl
nucleotid
polymorph
snp
hepatocyt
growth
factor
rab
gtpase
activ
protein
interleukin
cadherin
neg
regul
ubiquitin
like
protein
collagen
type
xxvii
lysyl
oxidas
lox
identifi
genom
wide
associ
studi
gwa
risk
factor
keratoconu
howev
molecular
function
associ
snp
well
understood
gene
express
signatur
keratoconu
report
offer
new
insight
diseas
process
differenti
gene
express
analysi
debrid
corneal
epithelia
patient
keratoconu
show
dysregul
lox
collagen
collagen
alpha
collagen
iv
alpha
elev
express
matrix
metalloproteinas
posit
correl
reduc
collagen
express
clinic
sever
keratoconu
observ
indic
role
structur
deform
keratocon
cornea
gene
also
associ
elev
inflammatori
cytokin
corneal
epithelium
tear
keratoconu
patient
howev
cyclosporin
cya
treatment
tumor
necrosi
factor
stimul
corneal
epitheli
cell
inhibit
express
cultur
human
keratocyt
cell
hkc
stimul
three
differ
isoform
transform
growth
factor
iiii
show
deregul
indic
alter
signal
progress
keratoconu
similarli
signific
reduct
level
alcohol
dehydrogenas
class
betapolypeptid
cultur
keratocon
corneal
fibroblast
suggest
possibl
role
keratoconu
reduc
level
beta
actin
protein
essenti
cell
surviv
growth
along
human
antigen
r
hur
observ
keratocon
normal
cornea
transcript
translat
level
suggest
deregul
molecul
possibl
trigger
keratoconu
similar
reduct
gene
express
beta
actin
alpha
enolas
also
observ
superfici
keratoconu
epitheli
cell
compar
normal
cornea
suggest
degrad
protein
keratoconu
nielsen
et
al
perform
proteom
analysi
use
electrophoresi
follow
mass
spectrometri
keratoconu
patient
epithelia
compar
control
patient
epithelium
overexpress
gelsolin
gsn
alpha
enolas
enoa
suggest
plausibl
role
protein
pathogenesi
keratoconu
possibl
associ
role
structur
protein
enzym
keratoconu
molecul
act
prognost
diagnost
biomark
may
aid
treatment
diseas
list
molecular
marker
identifi
cultur
corneal
cell
human
cornea
summar
tabl
genom
studi
thu
far
remain
inconclus
term
molecular
explan
phenotyp
observ
strongli
correl
molecular
express
data
patient
cornea
howev
gene
protein
express
data
keratocon
cornea
show
deregul
import
factor
pathway
collagen
synthesi
inflamm
extracellular
matrix
structur
gene
pathway
wnt
signal
name
howev
clinic
difficult
obtain
corneal
tissu
diagnosi
molecular
profil
make
profil
tear
patient
attract
prospect
keratoconu
associ
tissu
degrad
involv
extracellular
matrix
remodel
collagen
defici
recent
increas
role
proinflammatori
cytokin
cell
adhes
molecul
matrix
metalloproteinas
enzym
link
immunosorb
assay
elisa
analysi
capillari
collect
tear
patient
keratoconu
three
differ
studi
show
elev
level
inflammatori
marker
thu
varieti
matrix
metalloproteinas
mmp
interleukin
il
tumor
necrosi
factor
tnf
elev
keratoconu
tear
studi
also
demonstr
higher
gelatinolyt
collagenolyt
activ
keratoconu
henc
patient
elev
level
treat
cya
month
show
improv
corneal
topographi
character
reduc
diseas
progress
local
flatten
low
tear
anoth
studi
tear
keratoconu
patient
analyz
elisa
secretedfrizzl
relat
protein
protein
associ
wnt
signal
pathway
observ
lower
level
compar
agematch
control
indic
novel
signal
pathway
alter
keratoconu
tabl
tear
cytokin
analysi
perform
determin
effect
collagen
crosslink
tear
fluid
composit
show
alter
tear
cytokin
level
discoveri
signific
clinic
import
aid
furthermor
preexist
inform
base
differ
experiment
methodolog
enhanc
reliabl
preselect
marker
high
specif
sensit
target
specif
biochem
assay
make
reliabl
clinic
relev
detect
molecular
chang
qualit
quantit
manner
mass
spectrometr
analysi
protein
biomark
dual
advantag
survey
unknown
speci
therebi
discov
novel
molecular
chang
repertoir
protein
quantifi
chang
multiplex
manner
use
nanolc
tandem
mass
spectrometri
approach
tear
keratoconu
patient
compar
healthi
control
identifi
elev
cytokeratin
matrix
metalloproteinas
mammoglobin
b
addit
lipocalin
lcn
lysozym
c
lyz
immunoglobulin
alpha
kappa
igka
igkc
precursor
prolactin
deregul
keratoconu
tear
analysi
use
approach
identifi
immunoglobulin
kappa
chain
lactoferrin
ltf
reduc
keratoconu
use
complimentari
proteom
approach
lcm
e
mass
spectral
data
acquir
dataindepend
acquisit
mode
ms
e
acera
et
al
shown
signific
decreas
level
cystatin
higher
tear
patient
keratoconu
moreov
balasubramanium
et
al
demonstr
reduct
total
tear
protein
keratoconu
patient
protein
level
gross
cystic
diseas
fluid
prolactininduc
protein
pip
found
elev
tear
patient
proteom
analysi
suggest
applic
prognost
marker
keratoconu
tabl
one
major
challeng
tear
proteom
wide
dynam
rang
tear
protein
discuss
earlier
certain
protein
due
high
abund
abl
mask
identif
low
abund
protein
comparison
level
abund
protein
tear
serum
show
tear
fluid
similar
protein
abund
serum
though
fraction
help
resolv
abund
complex
limit
factor
protein
isoelectr
point
hydrophob
gelfre
approach
overcom
limit
coupl
fraction
method
cation
exchang
chromatographi
aid
resolv
sampl
abund
complex
metabol
chang
consequ
diseas
also
diagnos
tear
tear
metabolom
analysi
lcm
among
subject
clinic
defin
group
healthi
keratoconu
patient
rgp
len
keratoconu
correct
identifi
differ
metabolit
among
metabolit
associ
glycolysi
gluconeogenesi
urea
cycl
show
signific
chang
keratoconu
tear
thu
chang
underli
molecular
signal
secret
pathway
due
keratoconu
could
diseas
specif
affect
numer
biolog
process
metabolit
analysi
target
mass
spectrometri
perform
cultur
human
corneal
keratocyt
kck
human
corneal
fibroblast
hcf
hkc
detect
metabolit
major
involv
oxid
stress
pathway
impli
import
keratoconu
tear
protein
lyz
ltf
lcn
also
report
downregul
de
besid
tear
cytokin
il
elev
keratoconu
also
shown
similar
express
de
indic
certain
similar
molecular
chang
among
two
diseas
condit
henc
imper
practic
caution
consid
tear
molecular
chang
biomark
specif
diseas
albeit
recent
studi
shown
matrix
metalloproteinas
igkc
cell
adhes
molecul
specif
regul
keratoconu
indic
probabl
exclus
role
keratoconu
addit
reduc
level
specif
diseas
highlight
molecular
pathway
target
diseas
correct
sinc
collagen
crosslink
current
surgic
treatment
avail
keratoconu
reduct
natur
collagen
cross
linker
perhap
expect
molecular
pathway
lead
elev
collagenolyt
factor
present
anoth
attract
target
therapi
sinc
larg
sampl
studi
indic
broad
rang
express
factor
imper
tune
futur
treatment
modal
base
specif
molecular
target
correct
pathway
could
possibl
tearbas
biomark
profil
understood
inflamm
one
primari
driver
keratoconu
therefor
surpris
marker
keratoconu
de
similar
howev
amplitud
deregul
marker
correl
diseas
phenotyp
distinct
amongst
differ
disord
inflammatori
driver
larg
sampl
cohort
studi
would
valid
role
protein
specif
potenti
biomark
keratoconu
therefor
accumul
inform
marker
consid
applic
diagnosi
eg
elev
along
reduct
marker
lox
tear
give
specif
diagnosi
keratoconu
mani
factor
deregul
corneal
tissu
epithelium
stroma
level
well
tear
valid
import
biolog
process
specif
diseas
establish
differ
group
advent
high
throughput
technolog
multiplex
cytokin
bead
array
quantit
mass
spectrometri
multipl
reaction
monitor
mrm
assay
multipl
candid
marker
valid
rel
shorter
time
larger
cohort
patient
zhou
et
al
demonstr
quantit
tear
protein
mrm
assay
multiplex
valid
also
establish
uniqu
molecular
fingerprint
diseas
appropri
way
diagnos
treat
keratoconu
tear
fluid
sourc
biomark
ocular
system
condit
well
studi
shown
translat
potenti
moreov
noninvas
way
collect
tear
make
optim
biolog
fluid
studi
minim
discomfort
patient
studi
perform
tear
fluid
patient
keratoconu
provid
insight
patholog
diseas
reveal
probabl
prognost
well
diagnost
biomark
diseas
importantli
recent
studi
data
tear
analysi
establish
definit
role
inflamm
driver
corneal
collagen
loss
deform
keratoconu
patient
elev
cytokin
move
tandem
elev
matrix
degrad
enzym
reduc
level
collagen
collagen
crosslink
enzym
result
diseas
term
keratoconu
inflammaxi
uniqu
molecular
signal
fingerprint
identifi
diseas
relat
patholog
advanc
technolog
high
resolut
high
sensit
mass
spectrometri
enabl
map
tear
fluid
patient
also
heterogen
keratoconu
patholog
multiom
approach
integr
data
proteom
lipidom
metabolom
need
hour
studi
tear
fluid
import
sourc
biomark
keratoconu
lead
effect
prognosi
treatment
diseas
